Indian Journal of Urology Users online:3333  
IJU
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size
This article has been cited by
1Renal-cell carcinoma – novel concepts of classification
Maria Pyda-Karwicka,Malwina Karwicka,Magdalena Orlowska,Mariusz Krata,Agnieszka Pedrycz
Polish Journal of Public Health.2019;129(2)61
[DOI]
2Pharmacophore-based in silico high-throughput screening to identify novel topoisomerase-I inhibitors
Supriya Singh,Sucheta Das,Anubhuti Pandey,Swapnil Sharma,Sarvesh Paliwal
Medicinal Chemistry Research.2013;22(11)5356
[DOI]
3Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography
Vincent G. Bird,Prashanth Kanagarajah,Gaston Morillo,Daniel J. Caruso,Rajinikanth Ayyathurai,Raymond Leveillee,Merce Jorda
World Journal of Urology.2011;29(6)787
[DOI]
4Expression of secretagogin in clear-cell renal cell carcinomas is associated with a high metastasis rate
Aysegül Ilhan,Dashurie Neziri,Magdalena Maj,Peter R. Mazal,Martin Susani,Wolfgang Base,Wolfgang Gartner,Ludwig Wagner
Human Pathology.2011;42(5)641
[DOI]
5Combination of mTOR and MAPK Inhibitors—A Potential Way to Treat Renal Cell Carcinoma
Ashutosh Chauhan,Deepak Semwal,Satyendra Mishra,Sandeep Goyal,Rajendra Marathe,Ruchi Semwal
Medical Sciences.2016;4(4)16
[DOI]
  Search 
  The Journal 
  The Association 
  Site Statistics 
  Addresses 
  e-Alerts 
  Online Submission 

Submit Articles

Alerts

Join us